Hydroxychloroquine, a drug often used in the treatment of SLE with ability to reduce sensitivity of the skin to UV exposure, can inhibit Th17 cell expansion and IL-17 production [81]. The gene discussed is IL17A; the disease is systemic lupus erythematosus.